Trial Profile
A study to compare the rates of real world CNS events in patients treated with enzalutamide (ENZ) or bicalutamide (BIC)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Apr 2016
Price :
$35
*
At a glance
- Drugs Bicalutamide (Primary) ; Enzalutamide (Primary)
- Indications Prostate cancer
- Focus Adverse reactions
- 04 Apr 2016 New trial record